[1]
|
Chow, L.Q.M. (2020) Head and Neck Cancer. The New England Journal of Medicine, 382, 60-72. https://doi.org/10.1056/NEJMra1715715
|
[2]
|
Baxi, S.S., Pinheiro, L.C., Patil, S.M., et al. (2014) Causes of Death in Long-Term Survivors of Head and Neck Cancer. Cancer, 120, 1507-1513. https://doi.org/10.1002/cncr.28588
|
[3]
|
Pignon, J.P., Bourhis, J., Domenge, C., et al. (2000) Chemotherapy Added to Locoregional Treatment for Head and Neck Squamous-Cell Carcinoma: Three Meta-Analyses of Updated Individual Data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. The Lancet, 355, 949-955. https://doi.org/10.1016/S0140-6736(00)90011-4
|
[4]
|
Pignon, J.P., le Maître, A., Maillard, E., et al. (2009) Meta-Analysis of Chemotherapy in Head and Neck Cancer (MACH-NC): An Update on 93 Randomised Trials and 17,346 Patients. Radiotherapy and Oncology, 92, 4-14. https://doi.org/10.1016/j.radonc.2009.04.014
|
[5]
|
Wendt, T.G., Grabenbauer, G.G., Rödel, C.M., et al. (1998) Simultaneous Radiochemotherapy versus Radiotherapy Alone in Advanced Head and Neck Cancer: A Randomized Multicenter Study. Journal of Clinical Oncology, 16, 1318-1324. https://doi.org/10.1200/JCO.1998.16.4.1318
|
[6]
|
Bernier, J., Domenge, C., Ozsahin, M., et al. (2004) Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer. The New England Journal of Medicine, 350, 1945-1952. https://doi.org/10.1056/NEJMoa032641
|
[7]
|
Cooper, J.S., Zhang, Q., Pajak, T.F., et al. (2012) Long-Term Follow-Up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology, Biology, Physics, 84, 1198-1205. https://doi.org/10.1016/j.ijrobp.2012.05.008
|
[8]
|
Cooper, J.S., Pajak, T.F., Forastiere, A.A., et al. (2004) Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck. The New England Journal of Medicine, 350, 1937-1944. https://doi.org/10.1056/NEJMoa032646
|
[9]
|
Laramore, G.E., Scott, C.B., Al-Sarraf, M., et al. (1992) Adjuvant Chemotherapy for Resectable Squamous Cell Carcinomas of the Head and Neck: Report on Intergroup Study 0034. International Journal of Radiation Oncology, Biology, Physics, 23, 705-713. https://doi.org/10.1016/0360-3016(92)90642-U
|
[10]
|
Caudell, J.J., Gillison, M.L., Maghami, E., et al. (2022) NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. Journal of the National Comprehensive Cancer Network, 20, 224-234. https://doi.org/10.6004/jnccn.2022.0016
|
[11]
|
Lacas, B., Carmel, A., Landais, C., et al. (2021) Meta-Analysis of Chemotherapy in Head and Neck Cancer (MACH-NC): An Update on 107 Randomized Trials and 19,805 Patients, on Behalf of MACH-NC Group. Radiotherapy and Oncology, 156, 281-293. https://doi.org/10.1016/j.radonc.2021.01.013
|
[12]
|
Holoye, P.Y., Grossman, T.W., Toohill, R.J., et al. (1985) Randomized Study of Adjuvant Chemotherapy for Head and Neck Cancer. Otolaryngology-Head and Neck Surgery, 93, 712-717. https://doi.org/10.1177/019459988509300604
|
[13]
|
Kun, L.E., Toohill, R.J., Holoye, P.Y., et al. (1986) A Randomized Study of Adjuvant Chemotherapy for Cancer of the Upper Aerodigestive Tract. International Journal of Radiation Oncology, Biology, Physics, 12, 173-178. https://doi.org/10.1016/0360-3016(86)90090-8
|
[14]
|
Taylor 4th, S.G., Applebaum, E., Showel, J.L., et al. (1985) A Randomized Trial of Adjuvant Chemotherapy in Head and Neck Cancer. Journal of Clinical Oncology, 3, 672-679. https://doi.org/10.1200/JCO.1985.3.5.672
|
[15]
|
Ang, K.K., Trotti, A., Brown, B.W., et al. (2001) Randomized Trial Addressing Risk Features and Time Factors of Surgery Plus Radiotherapy in Advanced Head-and-Neck Cancer. International Journal of Radiation Oncology, Biology, Physics, 51, 571-578. https://doi.org/10.1016/S0360-3016(01)01690-X
|
[16]
|
Bernier, J., Cooper, J.S., Pajak, T.F., et al. (2005) Defining Risk Levels in Locally Advanced Head and Neck Cancers: A Comparative Analysis of Concurrent Postoperative Radiation Plus Chemotherapy Trials of the EORTC (#22931) and RTOG (# 9501). Head & Neck, 27, 843-850. https://doi.org/10.1002/hed.20279
|
[17]
|
Rosenthal, D.I., Liu, L., Lee, J.H., et al. (2002) Importance of the Treatment Package Time in Surgery and Postoperative Radiation Therapy for Squamous Carcinoma of the Head and Neck. Head & Neck, 24, 115-126. https://doi.org/10.1002/hed.10038
|
[18]
|
Cooper, J.S., Pajak, T.F., Forastiere, A., et al. (1998) Precisely Defining High-Risk Operable Head and Neck Tumors Based on RTOG #85-03 and #88-24: Targets for Postoperative Radiochemotherapy? Head & Neck, 20, 588-594. https://doi.org/10.1002/(SICI)1097-0347(199810)20:7<588::AID-HED2>3.0.CO;2-F
|
[19]
|
Dewit, L. (1987) Combined Treatment of Radiation and Cisdiamminedichloroplatinum (II): A Review of Experimental and Clinical Data. International Journal of Radiation Oncology, Biology, Physics, 13, 403-426. https://doi.org/10.1016/0360-3016(87)90015-0
|
[20]
|
Bachaud, J.M., Cohen-Jonathan, E., Alzieu, C., et al. (1996) Combined Postoperative Radiotherapy and Weekly Cisplatin Infusion for Locally Advanced Head and Neck Carcinoma: Final Report of a Randomized Trial. International Journal of Radiation Oncology, Biology, Physics, 36, 999-1004. https://doi.org/10.1016/S0360-3016(96)00430-0
|
[21]
|
Johnson, J.T., Myers, E.N., Schramm Jr., V.L., et al. (1987) Adjuvant Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck. Journal of Clinical Oncology, 5, 456-458. https://doi.org/10.1200/JCO.1987.5.3.456
|
[22]
|
Tobias, J.S., Monson, K., Gupta, N., et al. (2010) Chemoradiotherapy for Locally Advanced Head and Neck Cancer: 10-Year Follow-Up of the UK Head and Neck (UKHAN1) Trial. The Lancet Oncology, 11, 66-74. https://doi.org/10.1016/S1470-2045(09)70306-7
|
[23]
|
(1987) Adjuvant Chemotherapy for Advanced Head and Neck Squamous Carcinoma. Final Report of the Head and Neck Contracts Program. Cancer, 60, 301-311. https://doi.org/10.1002/1097-0142(19870801)60:3<301::AID-CNCR2820600306>3.0.CO;2-V
|
[24]
|
Jacobs, C. and Makuch, R. (1990) Efficacy of Adjuvant Chemotherapy for Patients with Resectable Head and Neck Cancer: A Subset Analysis of the Head and Neck Contracts Program. Journal of Clinical Oncology, 8, 838-847. https://doi.org/10.1200/JCO.1990.8.5.838
|
[25]
|
Hitt, R., López-Pousa, A., Martínez-Trufero, J., et al. (2005) Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer. Journal of Clinical Oncology, 23, 8636-8645. https://doi.org/10.1200/JCO.2004.00.1990
|
[26]
|
Kubota, A., Nakatani, E., Tsukahara, K., et al. (2018) Adjuvant Chemotherapy with S-1 after Curative Chemoradiotherapy in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck: Reanalysis of the ACTS-HNC Study. PLOS ONE, 13, e0198391. https://doi.org/10.1371/journal.pone.0198391
|
[27]
|
Tsukahara, K., Kubota, A., Hasegawa, Y., et al. (2015) Randomized Phase III Trial of Adjuvant Chemotherapy with S-1 after Curative Treatment in Patients with Squamous-Cell Carcinoma of the Head and Neck (ACTS-HNC). PLOS ONE, 10, e0116965. https://doi.org/10.1371/journal.pone.0116965
|
[28]
|
Posner, M.R., Hershock, D.M., Blajman, C.R., et al. (2007) Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer. The New England Journal of Medicine, 357, 1705-1715. https://doi.org/10.1056/NEJMoa070956
|